Breast Cancer Task Force Must Take More Active Role In RFP Development, New Chairman Insists
In Brief: FDA To Review Preclinical Testing, Phase I Protocols At Open Advisory Group Meeting
FDA Pettiness Holds Up Trials with Promising Anticancer Drugs
FDA Proposes Guidelines For Testing New Anticancer Drugs
Breast Cancer Progress Report Summaries
Shubick Committee Support New System for NCU Review, Action On Chemicals
Trending Stories
- In the Headlines: Is oncology ready to move away from animal testing?
- Imaging’s ride to the bottom in clinical trials—and why it matters now
- FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts
- Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology - The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic